Sandeep Kulkarni

Co-Founder, Chief Executive Officer and Director
Zura Bio

Sandeep Kulkarni, MD, is a co-founder of Zura and serves as its Chief Executive Officer and Director. He has served on Zura’s Board of Directors since March 2022 and was appointed Chief Executive Officer in January 2026.

Dr. Kulkarni is also the co founder of Tourmaline Bio, where he led the company as Chief Executive Officer from September 2021 through its acquisition by Novartis, which closed in October 2025. Prior to co founding Tourmaline Bio, he was a Managing Director at KVP Capital from August 2020 to June 2022, focusing on biotechnology investments and company formation.

Earlier in his career, Dr. Kulkarni held multiple roles at Roivant Sciences from July 2018 to June 2020, including Chief Operating Officer of Immunovant, Inc., Vice President of Special Projects, and Ombudsman to the Investment Committee. Prior to Roivant, he was an Investment Analyst on the life sciences team at QVT Financial LP from April 2013 to August 2017. From August 2009 to May 2012, he worked at The Boston Consulting Group, Inc., first as a consultant and later as a project leader advising biopharmaceutical companies on strategic and operational initiatives.

Dr. Kulkarni earned a Bachelor of Arts in Economics from Harvard College and a Doctor of Medicine from the University of California, San Francisco